OTCMKTS:CMXCCell MedX Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cell MedX Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.59 +0.02 (+2.63 %) (As of 07/7/2020 04:00 PM ET) Add Compare Share Today's Range$0.57Now: $0.59▼$0.5950-Day Range$0.56MA: $0.61▼$0.6652-Week Range$0.10Now: $0.59▼$1.69Volume35,663 shsAverage Volume73,267 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Cell MedX Corp., a development stage company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, and high blood pressure. It also develops and manufactures eBalance technology that is in the research and development stage to manage diabetes mellitus and its complications. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada. Cell MedX Corp. is a subsidiary of Wisdom Homes of America, Inc.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Cell MedX. Previous Next 2.4 Community Rank Outperform VotesCell MedX has received 71 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCell MedX has received 77 “underperform” votes. (Add your “underperform” vote.)Community SentimentCell MedX has received 52.03% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Cell MedX and other stocks. Vote “Outperform” if you believe CMXC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CMXC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCell MedX does not currently pay a dividend.Dividend GrowthCell MedX does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cell MedX insiders have bought more of their company's stock than they have sold. Specifically, they have bought $621,535.00 in company stock and sold $0.00 in company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.08 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Conglomerates Sub-IndustryN/A SectorConglomerates Current SymbolOTCMKTS:CMXC Previous SymbolNASDAQ:CMXC CUSIPN/A CIK1493712 Webcellmedx.com Phone+1-310-5089398Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:CMXC Rates by TradingView Receive CMXC News and Ratings via Email Sign-up to receive the latest news and ratings for CMXC and its competitors with MarketBeat's FREE daily newsletter. Cell MedX (OTCMKTS:CMXC) Frequently Asked Questions How has Cell MedX's stock been impacted by COVID-19 (Coronavirus)? Cell MedX's stock was trading at $0.31 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CMXC shares have increased by 88.7% and is now trading at $0.5850. View which stocks have been most impacted by Coronavirus. Has Cell MedX been receiving favorable news coverage? News stories about CMXC stock have been trending negative this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cell MedX earned a news sentiment score of -2.1 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Cell MedX. Who are some of Cell MedX's key competitors? Some companies that are related to Cell MedX include 3 Sixty Risk Solutions (PTVYF), 8i Enterprises Acquisition (JFKKU), Acamar Partners Acquisition (ACAMU), Acquired Sales (AQSP), Act II Global Acquisition (ACTTU), AGBA Acquisition (AGBAU), Alberton Acquisition Corporation Units (ALACU), Allegro Merger Corp. Units (ALGRU), Alterola Biotech (ALTA), AMCI Acquisition Corp. Units (AMCIU), Andina Acquisition Corp. III (SAMAU), Apex Technology Acquisition (APXTU), Arvana (AVNI), ARYA Sciences Acquisition Corp. Units (ARYAU) and BIDVEST GRP LTD/S (BDVSY). View all competitors. What other stocks do shareholders of Cell MedX own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cell MedX investors own include Callon Petroleum (CPE), Himax Technologies (HIMX), Remark (MARK), Microvision (MVIS), Ritter Pharmaceuticals (RTTR), CytoDyn (CYDY), Linn Energy (LINEQ), Audioeye (AEYE), AmpliPhi Biosciences (ARMP) and Bank of America (BAC). Who are Cell MedX's key executives? Cell MedX's management team includes the following people: Mr. Frank E. McEnulty, CEO & Director (Age 63)Ms. Yanika Silina C.M.A., CPA, CFO, Treasurer, Corp. Sec. & Director (Age 41)Mr. Bradley S. Hargreaves, VP of Technology & Operations and Director (Age 60) What is Cell MedX's stock symbol? Cell MedX trades on the OTCMKTS under the ticker symbol "CMXC." How do I buy shares of Cell MedX? Shares of CMXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Cell MedX's stock price today? One share of CMXC stock can currently be purchased for approximately $0.59. What is Cell MedX's official website? The official website for Cell MedX is cellmedx.com. How can I contact Cell MedX? Cell MedX's mailing address is 123 W Nye Ln Ste 446, CARSON CITY, NV 89706-0899, United States. The company can be reached via phone at +1-310-5089398. This page was last updated on 7/8/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
